It is widely hypothesized that autoantibodies directly contribute to the prothrombotic state in the antiphospholipid syndrome (APS). The discovery that antiphospholipid autoantibodies are specific for phospholipid-binding plasma proteins (β2-glycoprotein I, prothrombin, etc.) has allowed a much more precise investigation of the interactions of autoantibodies and antigens, and the effects of these interaction on hemostastis. Recent studies suggest that two types of interactions may be important in the pathophysiology of APS: (1) antibody cross-linking of membrane bound antigens may alter the kinetics of phospholipid-dependent reactions; and (2) antibody cross-linking of antigens bound to cell surface receptors may trigger signal transduction and cellular activation. In light of these findings, previous reports implicating various mechanisms of autoantibody-mediated thrombosis are being re-evaluated.
BlankM, CohenJ, ToderV, ShoenfeldY.Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.Proc Natl Acad Sci USA1991; 88: 3069–3073.
2.
BranchDW, DudleyDJ, MitchellMD.IgG fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss.Am J Obset Gynecol1990; 163: 210–216.
3.
PierangeliSS. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid syndrome.Thromb Haemost1995; 74: 1361–1367.
4.
RoubeyRAS, PrattCW, BuyonJP, WinfieldJB.Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glyoprotein I.J Clin Invest1992; 90: 1100–1104.
5.
WillemsGM. Role of divalency in the high-affinity binding of anticardiolipin antibody-β2-glycoprotein I complexes to lipid membranes.Biochemistry1996; 35: 13833–13842.
6.
ArnoutJ. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoproetin I complexes on phospholipid surfaces.Thromb Haemost1998; 79: 79–86.
7.
CompPC, DeBaultLE, EsmonNL, EsmonCT.Human thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants.Blood1983; 62 (Suppl 1): 299a (Abstract).
8.
MarciniakE, RomondEH.Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.Blood1989; 74: 2426–2432.
9.
MaliaRG, KitchenS, GreavesM, PrestonFE.Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies.Br J Haematol1990; 79: 101–107.
10.
OostingJD. Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?Blood1993; 81: 2618–2625.
11.
HalbmayerW-M, HaushoferA, SchönR, FischerM.Influence of lupus antibodagulant on a commercially available kit for APC-resistance.Thromb Haemost1994; 72: 645–646.
12.
KeelingDM. β2-glycoprotein I inhibits the thrombin/thrombomodulin dependent activation of protein C.Blood1991; 78: 184a (Abstract).
13.
OostingJD. In vitro studies of antiphospholipid antibodies and its cofactor, beta-2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation.Thromb Haemost1991; 66: 666–671.
14.
MatsudaJ. Inhibitory activity of anti-β2-glycoprotein I antibody on factor Va degradation by activated-protein C and its cofactor protein S.Am J Hematol1995; 49: 89–91.
15.
ShibataS. Autoantibodies to haparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes.Blood1994; 83: 2532–2540.
16.
ShiW, ChongBH, HoggPJ, ChestermanCN.Anticardiolipin antibodies block the inhibition by β2-glycoprotein I of the factor Xa generating activity of platelets.Thromb Haemost1993; 70: 342–345.
17.
Rand. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.Am J Obstet Gynecol1994; 171: 1566–1572.
18.
RandJH. Pregnancy loss in the antiphospholipid-antibody syndrome—A possible thrombogenic mechanism.N Engl J Med1997; 337: 154–160.
19.
VioliF. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.Br Med J1990; 300: 1099–1102.
20.
SanfelippoMJ, DraynaCJ.Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis.Am J Clin Pathol1982; 77: 275–279.
21.
KilleenAA, MeyerKC, VogtJM, EdsonJR.Kallikrein inhibition and C1-esterase inhibitor levels in patients with lupus inhibitor.Am J Clin Pathol1987; 88: 223–228.
22.
SchousboeI, RasmussenMS.Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by β2-glycoprotein I and anti-β2-glycoprotein I.Thromb Haemost1995; 73: 798–804.
23.
KornbergA, BlankM, KaufmanS, ShoenfeldY.Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.J Immunol1994; 153: 1328–1332.
24.
CuadradoMJ. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression.Arthritis Rheum1997; 40: 834–841.
25.
GinsbergJS. Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodie: evidence for a prothromobitc state.Blood1993; 81: 2958–2963.
26.
OostingJD. Antiphospholipid antibody positive sera enhanced endothelial cell procoagulant activity—studies in a thrombosis model.Thromb Haemost1992; 68: 278–284.
27.
Del PapaN. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules.Clin Exp Rheumatol1995; 13: 179–185.
28.
SimantovR. Activation of cultured vascular endothelial cells by antiphospholipid antibodies.J Clin Invest1995; 96: 2211–2219.
